Bioventus Inc. — Director's Dealing 2021

Feb 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bioventus Inc. (BVS)
CIK: 0001665988
Period of Report: 2021-02-11

Reporting Person: Nosenzo John (Chief Commercial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-11	Restricted Stock Units	$	A	1470	Acquired		Class A Common Stock (1470)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2: The restricted stock units vest on February 11, 2022.